LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -37.00%-2.24M | 107.71%605K | -46.65%-98.4M | -671.83%-32.86M | 71.07%43.73M | -104.02%-1.64M | -161.08%-7.85M | 8.59%-67.1M | -97.49%5.75M | -84.40%25.56M |
Net income from continuing operations | -122.88%-8.21M | -177.84%-47.82M | -1,035.25%-339.09M | -284.36%-53.18M | -178.69%-2.42M | -120.97%-3.68M | -783.29%-17.21M | -625.40%-29.87M | -92.23%28.85M | -94.16%3.07M |
Operating gains losses | ---- | ---- | ---- | ---3.09M | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 26.52%1.83M | -10.81%1.56M | -26.76%1.33M | -28.12%6.16M | -41.46%1.16M | -29.04%1.44M | -22.41%1.75M | -21.42%1.81M | -21.82%8.57M | -16.24%1.98M |
Deferred tax | 102.59%49K | 98.94%-65K | 3,091.38%296.78M | -760.18%-17.89M | 102.12%73K | -150.43%-1.89M | -1,052.06%-6.15M | -438.49%-9.92M | 100.99%2.71M | 5.03%-3.44M |
Other non cash items | -1,450.00%-405K | -10,081.82%-2.24M | 1,003.82%1.73M | -92.74%490K | 60.89%325K | -98.65%30K | -101.34%-22K | -94.15%157K | -67.22%6.75M | -96.32%202K |
Change In working capital | 61.93%-2.88M | 1,327.69%38.11M | -71.54%-67.92M | 91.48%-6.83M | 165.54%37.65M | -229.86%-7.55M | 181.50%2.67M | 59.12%-39.59M | -230.66%-80.12M | -85.32%14.18M |
-Change in receivables | -85.38%-46.69M | 31.13%-17.49M | 12.44%22.43M | -138.27%-14.48M | 100.97%16.15M | -809.86%-25.19M | -47.13%-25.39M | -54.15%19.95M | 564.62%37.83M | 151.63%8.04M |
-Change in inventory | -197.57%-57.93M | 74.90%33.92M | 9.71%-24.99M | 151.24%20.87M | 85.09%48.61M | 28.92%-19.47M | 393.37%19.4M | 16.11%-27.67M | -453.95%-40.72M | -23.84%26.26M |
-Change in prepaid assets | 15.80%-3.21M | 391.28%845K | 29.81%-2.28M | -196.55%-7.65M | -122.71%-754K | 49.77%-3.82M | 106.31%172K | -121.78%-3.25M | 145.23%7.92M | 200.72%3.32M |
-Change in payables and accrued expense | 143.91%104.31M | 116.21%22.86M | -125.73%-62.36M | 95.65%-4.23M | 0.13%-29.94M | 23.66%42.77M | -50.89%10.57M | 77.58%-27.63M | -272.61%-97.11M | -144.99%-29.98M |
-Change in other working capital | 134.85%645K | 2.16%-2.04M | 27.43%-717K | -111.19%-1.34M | -45.20%3.58M | -169.33%-1.85M | -216.14%-2.08M | -202.38%-988K | -37.73%11.96M | -34.18%6.54M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -37.00%-2.24M | 107.71%605K | -46.65%-98.4M | -671.83%-32.86M | 71.07%43.73M | -104.02%-1.64M | -161.08%-7.85M | 8.59%-67.1M | -97.49%5.75M | -84.40%25.56M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -104.42%-1.94M | -101.28%-716K | 38.69%10.73M | 1,553.29%121.9M | 230.33%14.47M | 412.62%43.98M | 127.37%55.73M | 200.05%7.74M | 94.16%-8.39M | 80.39%-11.1M |
Net PPE purchase and sale | -7,995.83%-1.94M | -49.79%-716K | -99.59%-964K | 55.90%-1.52M | -121.07%-535K | 98.74%-24K | 38.24%-478K | 7.12%-483K | 37.84%-3.45M | 65.67%-242K |
Net business purchase and sale | --0 | --0 | ---12.31M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net investment purchase and sale | --0 | --0 | 192.04%24M | 2,597.92%123.42M | 238.16%15M | 461.96%44M | 122.30%56.2M | 213.96%8.22M | 96.42%-4.94M | 80.58%-10.86M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -104.42%-1.94M | -101.28%-716K | 38.69%10.73M | 1,553.29%121.9M | 230.33%14.47M | 412.62%43.98M | 127.37%55.73M | 200.05%7.74M | 94.16%-8.39M | 80.39%-11.1M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 100.96%103K | 98.70%-202K | 91.37%-598K | 47.84%-90.38M | -533.87%-57.11M | 7.99%-10.76M | 88.71%-15.58M | 52.48%-6.93M | -1,652.14%-173.27M | -328.84%-9.01M |
Net issuance payments of debt | ---- | ---- | ---- | 63.00%-46.25M | ---- | ---- | ---- | ---- | ---125M | --0 |
Net common stock issuance | 109.11%770K | 100.01%1K | 151.53%1.38M | -3.63%-36.12M | -26.15%-10M | -7.54%-8.45M | -28.48%-15M | 63.84%-2.68M | -565.41%-34.86M | -3,091.32%-7.93M |
Net other financing activities | 71.15%-667K | 65.18%-203K | 53.49%-1.98M | 40.28%-8.01M | 20.41%-862K | 39.78%-2.31M | 55.60%-583K | 40.75%-4.25M | 22.84%-13.41M | 54.23%-1.08M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 100.96%103K | 98.70%-202K | 91.37%-598K | 47.84%-90.38M | -533.87%-57.11M | 7.99%-10.76M | 88.71%-15.58M | 52.48%-6.93M | -1,652.14%-173.27M | -328.84%-9.01M |
Net cash flow | ||||||||||
Beginning cash position | -29.95%133.04M | -15.31%133.66M | -0.46%222.71M | -44.22%223.74M | 1.76%220.98M | -6.58%189.91M | -48.31%157.83M | -44.22%223.74M | 22.41%401.09M | -26.72%217.16M |
Current changes in cash | -112.93%-4.08M | -100.97%-313K | -33.15%-88.27M | 99.24%-1.34M | -80.16%1.08M | 110.89%31.58M | 132.09%32.29M | 30.74%-66.29M | -332.85%-175.91M | -94.81%5.45M |
Effect of exchange rate changes | 345.17%1.24M | -51.47%-309K | -301.82%-777K | 121.91%316K | -42.73%642K | 53.57%-507K | 85.60%-204K | 812.96%385K | 31.72%-1.44M | 374.75%1.12M |
End cash Position | -41.08%130.2M | -29.95%133.04M | -15.31%133.66M | -0.46%222.71M | -0.46%222.71M | 1.76%220.98M | -6.58%189.91M | -48.31%157.83M | -44.22%223.74M | -44.22%223.74M |
Free cash flow | -151.93%-4.19M | 98.67%-111K | -47.03%-99.37M | -1,594.91%-34.38M | 70.59%43.19M | -104.28%-1.66M | -168.95%-8.33M | 8.58%-67.59M | -98.97%2.3M | -84.48%25.32M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |